Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210(bcr/abl): A novel transgenic model for human Ph1-positive leukemias

Blood

Volumn 91, Issue 6, 1998, Pages 2067-2075

  Honda, Hiroaki ^b   Oda, Hideaki ^b   Suzuki, Takahiro ^b   Takahashi, Tsuyoshi ^b   Witte, Owen N ^b   Ozawa, Keiya ^b   Ishikawa, Takatoshi ^b   Yazaki, Yoshio ^b   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; CHIMERIC PROTEIN; PROTEIN TYROSINE KINASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLAST CELL CRISIS; CELL PROLIFERATION; CHROMOSOME 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; LYMPHOBLAST; MALE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; PROTEIN INDUCTION; THROMBOCYTOSIS; TRANSGENIC MOUSE;

EID: 0032520986     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.6.2067     Document Type: Article

References (37)

1. Champlin RE, Golde DW: Chronic myelogenous leukemia: Recent advances. Blood 65:1039, 1985
2. Clark SS, Crist WM, Witte ON: Molecular pathogenesis of Ph-positive leukemias. Annu Rev Med 40:113, 1989
3. Rosenthal S, Canellos GP, Gralnick HR: Erythroblastic transformation of chronic granulocytic leukemia. Am J Med 63:116, 1977
4. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature (London) 243:290, 1973
5. Nowell PC, Hungerford DA: A minute chromosome in human chronic granulocytic leukemia. Science 132:1497, 1960
6. Groffen J, Stephenson JR, Heisterkamp N, deKlein A, Bartram CR, Grosveld G: Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36:93, 1984
7. Kurzrock R, Shtalrid M, Rommero P, Kloetzer WS, Talpas M, Trujillo JM, Blick M, Beran M, Gutterman JU: A novel c-abl protein product in Philadelphia-positive acute lymphoblastic leukaemia. Nature (London) 325:631, 1987
8. Chan LC, Karhi KK, Rayter SI, Heisterkamp N, Eridani S, Powles R, Lawler SD, Groffen J, Foulkes JG, Greaves MF, Wiedemann LM: A novel abl protein expressed in Philadelphia chromosome-positive acute lymphoblastic leukemia. Nature (London) 325:635, 1987
9. Walker LC, Ganesan TS, Dhut S, Gibbonas B, Lister TA, Rothbard J, Young BD: Novel chimaeric protein expressed in Philadelphia-positive acute lymphoblastic leukaemia. Nature (London) 329: 851, 1987
10. Hermans A, Heisterkamp N, von Lindern M, van Baal S, Meijer D, van der Plas D, Wiedemann LM, Groffen J, Bootsma D, Grosveld G: Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell 51:33, 1987
11. 1-positive ALL. Science 235:85, 1987
12. Konopka JB, Watanabe SM, Witte ON: An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 37:1035, 1983
13. bcr/abl gene of the Philadelphia chromosome. Science 247:824, 1990
14. Elefancy AG, Hariharan IK, Cory S: bcr-abl, the hallmark of chronic myeloid leukaemia in man, induces multiple haematopoietic neoplasms in mice. EMBO J 9:1069, 1990
15. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N: Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci USA 87:6649, 1990
16. Clark SS, Chen E, Fizzotti M, Witte ON, Malkovska V: BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets. J Virol 67:6033, 1993
17. Hariharan IK, Harris AW, Crawford M, Abud H, Webb E, Cory S, Adams JM: A bcr-v-abl oncogene induces lymphomas in transgenic mice. Mol Cell Biol 9:2798, 1989
18. Hariharan IK, Adams JM: bcr-abl gene renders myeloid cell line factor independent and tumorigenic: Potential autocrine model in chronic myeloid leukemia. Oncogene Res 3:387, 1988
19. bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice. Blood 85:2853, 1995
20. Voncken JW, Kaartinen V, Pattengale PK, Germeraad WTV, Groffen J, Heisterkamp N: BCR/ABL p210 and p190 cause distinct leukemia in transgenic mice. Blood 86:4603, 1995
21. Honda H, Yamashita Y, Ozawa K, Mano H: Cloning and characterization of mouse tec promoter. Biochem Biophys Res Commun 223:422, 1996
22. Honda H, Ozawa K, Yazaki Y, Hirai H: Identification of PU.1 and Sp1 as essential transcriptional factors for the promoter activity of mouse tec gene. Biochem Biophys Res Commun 234:376, 1997
23. Mano H, Ishikawa F, Nishida J, Hirai H, Takaku F: A novel protein-tyrosine kinase, tec, is preferentially expressed in liver. Oncogene 5:1781, 1990
24. Hogan B, Constantini F, Lacy E: Manipulating the Mouse Embryo, Cold Spring Harbor NY, Cold Spring Harbor Laboratory, 1986
25. Sambrook J, Fritsch EF, Maniatis T (eds): Molecular Cloning: A Laboratory Manual. Cold Spring Harbor NY, Cold Spring Harbor Laboratory, 1989
26. Chomczinski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
27. Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Hirai H, Ishikawa F, Takaku F: Mutations of the p53 gene in lymphoid leukemia. Blood 77:1153, 1991
28. Elefancy AG, Cory S: Hematologic disease induced in BALB/C mice by a BCRJABL retrovirus is influenced by the infection conditions. Mol Cell Biol 12:1755, 1992
29. Kelliher MA, Weckstein DJ, Knott AG, Wortis HH, Roseberg N: ABL oncogene directly stimulates two distinct target cells in bone marrow from 5-fluorouracil-treated mice. Oncogene 8:1249, 1993
30. Daley GQ: Animal models for BCR/ABL-induced leukemias. Leuk Lymphoma 11:57, 1993
31. Heisterkamp N, Jenster G, Kioussis D, Pattengale PK, Groffen J: Human BCR/ABL gene has a lethal effect on embryogenesis. Transgenic Res 1:45, 1991
32. Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J: Acute leukaemia in bcr/abl transgenic mice. Nature (London) 344:251, 1990
33. Iwamoto T, Takahashi M, Ito M, Hamatani K, Ohbayashi M, Wajjwalku W, Isobe K, Nakashima I: Aberrant melanocytosis and melanocytic tumor development in transgenic mice that carry a metallothionein/ret fusion gene. EMBO J 10:3167, 1991
34. Palmiter RD, Brinster RL: Transgenic mice. Cell 41:343, 1985
35. Palmiter RD, Norstedt G, Gelinas RE, Hammer RE, Brinster RL: Metallothionein-human GH fusion genes stimulate growth of mice. Science 222:809, 1983
36. Inokuchi K, Inoue T, Tojo A, Futaki M, Miyake K, Yamada T, Tanabe Y, Ohki I, Dan K, Ozawa K, Asano S, Nomura T: A possible correlation between the type of bcr/abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 78:3125, 1991
37. Cervantes F, Colomer D, Vives-Corrons JL, Rozman C, Montserrat E: Chronic myeloid leukemia of thrombocythemic onset: A CML subtype with distinct hematological and molecular features? Leukemia 10:1241, 1996